Estimated Glomerular Filtration Rate and the Risk of Inflammatory Bowel Disease in Adults: A Swedish Population-Based Study

被引:3
作者
Yang, Yuanhang [1 ]
Ludvigsson, Jonas F. [1 ,2 ,3 ]
Olen, Ola [4 ,5 ,6 ]
Sjolander, Arvid [1 ]
Carrero, Juan J. [1 ,7 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, SE-17177 Stockholm, Sweden
[2] Orebro Univ Hosp, Dept Paediat, Orebro, Sweden
[3] Columbia Univ, Dept Med, Coll Phys & Surg, Celiac Dis Ctr, New York, NY USA
[4] Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, Stockholm, Sweden
[5] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden
[6] Stockholm South Gen Hosp, Sachs Children & Youth Hosp Stockholm, Stockholm, Sweden
[7] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Nephrol, Stockholm, Sweden
关键词
chronic kidney disease; estimated glomerular filtration rate; inflammatory bowel disease; DIAGNOSTIC DELAY; IGA NEPHROPATHY; REGISTER; ALBUMINURIA; ASSOCIATION; PROGRESSION; TIME;
D O I
10.1093/ibd/izac267
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Kidney complications are common in patients with long-standing inflammatory bowel disease (IBD). Whether kidney complications, defined as low estimated glomerular filtration rate (eGFR), may predispose to later IBD is unknown. Methods We analyzed the association between eGFR and the risk of being subsequently diagnosed with IBD among 1 612 160 adults from Stockholm. The exposure was categories of eGFR, with 90 to 104 mL/min/1.73 m(2) as the reference. Cox regression models were used to investigate the association between eGFR, IBD, and IBD subtypes. Subgroup analyses included age strata, sex, education, and comorbidities. To explore the possibility of detection bias or reverse causation, we estimated IBD hazard ratios (HRs) after excluding cases and individuals censored during early years of follow-up. Results During a median of 9 years of follow-up, we detected 9663 cases of IBD (3299 Crohn's disease, 5072 ulcerative colitis, 1292 IBD unclassified). Lower eGFR levels were associated with higher IBD risk (for eGFR 30-59 mL/min/1.73 m(2): adjusted HR, 1.15; 95% confidence interval [CI], 1.01-1.33; and for eGFR <30 mL/min/1.73 m(2): adjusted HR, 1.65; 95% CI, 1.16-2.37). This association was stronger in magnitude for Crohn's disease (for eGFR 30-59 mL/min/1.73 m(2): HR, 1.33, 95% CI, 1.04-1.72; and for eGFR <30 mL/min/1.73 m(2): HR, 2.25; 95% CI, 1.26-3.99). Results were consistent across strata of age, comorbidities, and attained education but suggested the association between eGFR and IBD to be stronger in women (P for interaction <.05). Results attenuated but were robust to exclusion of early IBD cases. Conclusions We observed an association between reduced eGFR and the risk of developing IBD, which was stronger in magnitude for Crohn's disease.
引用
收藏
页码:718 / 725
页数:8
相关论文
共 40 条
  • [1] Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists
    Agrawal, Manasi
    Spencer, Elizabeth A.
    Colombel, Jean-Frederic
    Ungaro, Ryan C.
    [J]. GASTROENTEROLOGY, 2021, 161 (01) : 47 - 65
  • [2] Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994)
    Astor, BC
    Muntner, P
    Levin, A
    Eustace, JA
    Coresh, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) : 1401 - 1408
  • [3] Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
    Baumgart, Daniel C.
    Carding, Simon R.
    [J]. LANCET, 2007, 369 (9573) : 1627 - 1640
  • [4] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [5] East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
    Burisch, J.
    Pedersen, N.
    Cukovic-Cavka, S.
    Brinar, M.
    Kaimakliotis, I.
    Duricova, D.
    Shonova, O.
    Vind, I.
    Avnstrom, S.
    Thorsgaard, N.
    Andersen, V.
    Krabbe, S.
    Dahlerup, J. F.
    Salupere, R.
    Nielsen, K. R.
    Olsen, J.
    Manninen, P.
    Collin, P.
    Tsianos, E. V.
    Katsanos, K. H.
    Ladefoged, K.
    Lakatos, L.
    Bjornsson, E.
    Ragnarsson, G.
    Bailey, Y.
    Odes, S.
    Schwartz, D.
    Martinato, M.
    Lupinacci, G.
    Milla, M.
    De Padova, A.
    D'lnca, R.
    Beltrami, M.
    Kupcinskas, L.
    Kiudelis, G.
    Turcan, S.
    Tighineanu, O.
    Mihu, I.
    Magro, F.
    Barros, L. F.
    Goldis, A.
    Lazar, D.
    Belousova, E.
    Nikulina, I.
    Hernandez, V.
    Martinez-Ares, D.
    Almer, S.
    Zhulina, Y.
    Halfvarson, J.
    Arebi, N.
    [J]. GUT, 2014, 63 (04) : 588 - 597
  • [6] Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark
    Burisch, Johan
    Jess, Tine
    Egeberg, Alexander
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (13) : 2704 - +
  • [7] Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
    Busch, K.
    Ludvigsson, J. F.
    Ekstrom-Smedby, K.
    Ekbom, A.
    Askling, J.
    Neovius, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 57 - 68
  • [8] The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study
    Cantoro, Laura
    Di Sabatino, Antonio
    Papi, Claudio
    Margagnoni, Giovanna
    Ardizzone, Sandro
    Giuffrida, Paolo
    Giannarelli, Diana
    Massari, Alessandro
    Monterubbianesi, Rita
    Lenti, Marco Vincenzo
    Corazza, Gino Roberto
    Kohn, Anna
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (08) : 975 - 980
  • [9] Gut Dysbiosis and Kidney Diseases
    Cao, Chujin
    Zhu, Han
    Yao, Ying
    Zeng, Rui
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [10] The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care
    Carrero, Juan Jesus
    Elinder, Carl Gustaf
    [J]. JOURNAL OF INTERNAL MEDICINE, 2022, 291 (03) : 254 - 268